Results 91 to 100 of about 3,363,784 (294)
The burden of cancer at work: estimation as the first step to prevention [PDF]
, 2008 Objectives: Work-related cancers are largely preventa¬ble. The overall aim of this project is to estimate the current burden of cancer in Great Britain attributable to occupational factors, and identify carcinogenic agents, industries and occupations ...
Brown, T. P., Rushton, L., Hutchings, S.
core +1 more source
Advanced Science, EarlyView.ABSTRACT Gastric cancer (GC) is a major global health concern, as its prevention and treatment remain significant challenges. The 8‐oxoguanine (o8G) modification of circRNAs, alongside their capacity to orchestrate liquid‐liquid phase separation (LLPS) and autophagy, plays a pivotal role in driving tumor progression and determining therapeutic outcomes.
Lei Peng +8 more
wiley +1 more source
Chemotherapy for Invasive Bladder Cancer: Five Simple Rules Learned Over 30 Years
Bladder Cancer, 2015 Invasive, clinically non-metastatic bladder cancer has a cure rate of only 50% , when all T stages are considered. The pattern of relapse is dominated by systemic spread, provided that optimal surgery is practiced.
Derek Raghavan
doaj +1 more source
Concurrent Bladder Lymphoma and Bladder Cancer Presenting as Metastatic Bladder Cancer
The World Journal of Men's Health, 2012 Malignant lymphoma of the bladder is a rare lesion, representing approximately 0.2% of the primary lesions and approximately 1.8% of the secondary lesions. A disseminated lymphoma presenting as a bladder mass is an infrequent phenomenon. The authors report the case of a 71-year-old patient with concurrent bladder lymphoma and bladder cancer presenting ...
Kim, Jae Heon +5 more
openaire +2 more sources
Advanced Science, EarlyView.Aberrant GALNT7‐mediated O‐GalNAcylation stabilizes TAZ to drive gallbladder cancer progression through a feed‐forward transcriptional loop. Structure‐based screening identifies Olaparib as a potent GALNT7 antagonist that disrupts this oncogenic axis, providing an immediate therapeutic strategy for this aggressive malignancy.
Peng Qiu +11 more
wiley +1 more source
Bladder Cancer Molecular Taxonomy: Summary from a Consensus Meeting
Bladder Cancer, 2016 The advent of Omics technologies has been key to the molecular subclassification of urothelial bladder cancer. Several groups have used different strategies to this aim, with partially overlapping findings.
Seth P. Lerner +7 more
doaj +1 more source
What is a bladder cancer molecular subtype? – Counterpoint
, 2023 In an accompanying paper, Mattias Hoglund discusses on what is a bladder cancer molecular subtype. He emphasizes the need to consider the aim of tumor classification, which is obviously critical to the approach.
Real, Francisco X. +2 more
core +1 more source
CALB2 is a Mechanoresistance Gene in Metastatic Prostate Cancer
Advanced Science, EarlyView.Prostate cancer cell lines of differing origins were cultured over many passages while being subjected to semi‐lethal levels of fluid shear stress, representing the harsh mechanical environment these cells are subjected to in the circulation during the process of distant metastasis.
Abigail R. Fabiano +10 more
wiley +1 more source
Diabetes and Risk of Bladder Cancer: A Study Using the National Health Insurance Database in Taiwan
, 2012 Studies on the link between diabetes and bladder cancer in Asians are rare. We investigated the association between diabetes and incidence of bladder cancer by using a large national insurance database. A random sample of 1,000,000 individuals covered by
曾慶孝, TSENG, CHIN-HSIAO
core +1 more source
Bladder Cancer, 2018 Background: Adjuvant intravesical instillations with bacillus Calmette-Guérin (BCG) is the recommended treatment option for patients with intermediate-and high-risk non-muscle invasive bladder cancer (NMIBC).
Joep J. de Jong +4 more
doaj +1 more source